Availability of Transcatheter Aortic Valve Implantation Across Hospitals and Differences in Strategies and Clinical Outcomes in Patients with Severe Aortic Stenosis

There was a scarcity of data evaluating variations in treatment approaches and clinical outcomes for severe aortic stenosis (AS) between medical centers with and without availability of transcatheter aortic valve implantation (TAVI). Current study population was 2993 patients with severe AS enrolled in the CURRENT AS Registry-2 (2581 patients from 10 TAVI centers; 412 patients from 10 non-TAVI centers). TAVI centers more frequently opted for the initial aortic valve replacement (AVR) strategy compared to non-TAVI centers (60% and 40%, P < 0.001). Among patients with the initial AVR strategy, TAVI centers disproportionately favored the initial TAVI strategy compared to non-TAVI centers (71% and 23%, P < 0.001). No significant differences were observed in the risk of a composite of all-cause death or heart failure hospitalization between TAVI and non-TAVI centers in the entire study population (cumulative 3-year incidence: 32.0% and 31.0%, P = 0.37; adjusted hazard ratios: 0.92, 95% confidence intervals: 0.74-1.15, P = 0.45) or in conservative, initial AVR, initial surgical AVR, and initial TAVI strata. A substantial disparity exists in the treatment strategies for patients with severe AS between TAVI and non-TAVI centers. TAVI centers tended to perform AVR, particularly TAVI, earlier and more frequently. However, there was no discernible distinction in the risk of the composite of all-cause death or HF hospitalization between TAVI and non-TAVI centers. UMINID: UMIN000034169.

References

Leon M, Smith C, Mack M, Miller D, Moses J, Svensson L . Transcatheter aortic-valve implantation for aortic stenosis in patients who cannot undergo surgery. N Engl J Med. 2010; 363(17):1597-607. DOI: 10.1056/NEJMoa1008232. View

Smith C, Leon M, Mack M, Miller D, Moses J, Svensson L . Transcatheter versus surgical aortic-valve replacement in high-risk patients. N Engl J Med. 2011; 364(23):2187-98. DOI: 10.1056/NEJMoa1103510. View

Makkar R, Thourani V, Mack M, Kodali S, Kapadia S, Webb J . Five-Year Outcomes of Transcatheter or Surgical Aortic-Valve Replacement. N Engl J Med. 2020; 382(9):799-809. DOI: 10.1056/NEJMoa1910555. View

Leon M, Mack M, Hahn R, Thourani V, Makkar R, Kodali S . Outcomes 2 Years After Transcatheter Aortic Valve Replacement in Patients at Low Surgical Risk. J Am Coll Cardiol. 2021; 77(9):1149-1161. DOI: 10.1016/j.jacc.2020.12.052. View

Jorgensen T, Horsted Thyregod H, Ihlemann N, Nissen H, Petursson P, Kjeldsen B . Eight-year outcomes for patients with aortic valve stenosis at low surgical risk randomized to transcatheter vs. surgical aortic valve replacement. Eur Heart J. 2021; 42(30):2912-2919. PMC: 8347457. DOI: 10.1093/eurheartj/ehab375. View

Mack M, Leon M, Thourani V, Pibarot P, Hahn R, Genereux P . Transcatheter Aortic-Valve Replacement in Low-Risk Patients at Five Years. N Engl J Med. 2023; 389(21):1949-1960. DOI: 10.1056/NEJMoa2307447. View

Reardon M, Adams D, Kleiman N, Yakubov S, Coselli J, Deeb G . 2-Year Outcomes in Patients Undergoing Surgical or Self-Expanding Transcatheter Aortic Valve Replacement. J Am Coll Cardiol. 2015; 66(2):113-21. DOI: 10.1016/j.jacc.2015.05.017. View

Mack M, Leon M, Smith C, Miller D, Moses J, Tuzcu E . 5-year outcomes of transcatheter aortic valve replacement or surgical aortic valve replacement for high surgical risk patients with aortic stenosis (PARTNER 1): a randomised controlled trial. Lancet. 2015; 385(9986):2477-84. DOI: 10.1016/S0140-6736(15)60308-7. View

Sondergaard L, Steinbruchel D, Ihlemann N, Nissen H, Kjeldsen B, Petursson P . Two-Year Outcomes in Patients With Severe Aortic Valve Stenosis Randomized to Transcatheter Versus Surgical Aortic Valve Replacement: The All-Comers Nordic Aortic Valve Intervention Randomized Clinical Trial. Circ Cardiovasc Interv. 2016; 9(6). DOI: 10.1161/CIRCINTERVENTIONS.115.003665. View

10.

Leon M, Smith C, Mack M, Makkar R, Svensson L, Kodali S . Transcatheter or Surgical Aortic-Valve Replacement in Intermediate-Risk Patients. N Engl J Med. 2016; 374(17):1609-20. DOI: 10.1056/NEJMoa1514616. View

11.

Reardon M, Van Mieghem N, Popma J, Kleiman N, Sondergaard L, Mumtaz M . Surgical or Transcatheter Aortic-Valve Replacement in Intermediate-Risk Patients. N Engl J Med. 2017; 376(14):1321-1331. DOI: 10.1056/NEJMoa1700456. View

12.

Mack M, Leon M, Thourani V, Makkar R, Kodali S, Russo M . Transcatheter Aortic-Valve Replacement with a Balloon-Expandable Valve in Low-Risk Patients. N Engl J Med. 2019; 380(18):1695-1705. DOI: 10.1056/NEJMoa1814052. View

13.

Popma J, Deeb G, Yakubov S, Mumtaz M, Gada H, OHair D . Transcatheter Aortic-Valve Replacement with a Self-Expanding Valve in Low-Risk Patients. N Engl J Med. 2019; 380(18):1706-1715. DOI: 10.1056/NEJMoa1816885. View

14.

Horsted Thyregod H, Ihlemann N, Jorgensen T, Nissen H, Kjeldsen B, Petursson P . Five-Year Clinical and Echocardiographic Outcomes From the NOTION Randomized Clinical Trial in Patients at Lower Surgical Risk. Circulation. 2019; 139(24):2714-2723. DOI: 10.1161/CIRCULATIONAHA.118.036606. View

15.

Singh V, Badheka A, Patel S, Patel N, Thakkar B, Patel N . Comparison of Inhospital Outcomes of Surgical Aortic Valve Replacement in Hospitals With and Without Availability of a Transcatheter Aortic Valve Implantation Program (from a Nationally Representative Database). Am J Cardiol. 2015; 116(8):1229-36. DOI: 10.1016/j.amjcard.2015.07.039. View

16.

Tabata M, Kumamaru H, Ono A, Miyata H, Sato Y, Motomura N . The Association of In-Hospital Transcatheter Aortic Valve Replacement Availability on Outcomes of Surgical Aortic Valve Replacement in Elderly Patients. Circ J. 2020; 84(9):1599-1604. DOI: 10.1253/circj.CJ-20-0032. View

17.

Takeji Y, Taniguchi T, Morimoto T, Shirai S, Kitai T, Tabata H . Rationale, Design, and Baseline Characteristics of the CURRENT AS Registry-2. Circ J. 2022; 86(11):1769-1776. DOI: 10.1253/circj.CJ-21-1062. View

18.

Carroll J, Mack M, Vemulapalli S, Herrmann H, Gleason T, Hanzel G . STS-ACC TVT Registry of Transcatheter Aortic Valve Replacement. J Am Coll Cardiol. 2020; 76(21):2492-2516. DOI: 10.1016/j.jacc.2020.09.595. View

19.

Kang D, Park S, Lee S, Lee S, Kim D, Kim H . Early Surgery or Conservative Care for Asymptomatic Aortic Stenosis. N Engl J Med. 2019; 382(2):111-119. DOI: 10.1056/NEJMoa1912846. View

20.

Banovic M, Putnik S, Penicka M, Doros G, Deja M, Kockova R . Aortic Valve Replacement Versus Conservative Treatment in Asymptomatic Severe Aortic Stenosis: The AVATAR Trial. Circulation. 2021; 145(9):648-658. DOI: 10.1161/CIRCULATIONAHA.121.057639. View